Impaired coronary endothelium-dependent vasodilation is associated with microalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries

Diabetes Care

Volumn 29, Issue 1, 2006, Pages 107-112

  Cosson, Emmanuel ^a   Pham, Isabelle ^a   Valensi, Paul ^a   Pariès, Jacques ^a   Attali, Jean Raymond ^a   Nitenberg, Alain ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALBUMIN; ALPHA GLUCOSIDASE INHIBITOR; ANTILIPEMIC AGENT; CHOLESTEROL; CREATINE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOSORBIDE DINITRATE; METFORMIN; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR RISK; COLD PRESSOR TEST; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART INDEX; HEMODYNAMIC PARAMETERS; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN URINE LEVEL; UNIVARIATE ANALYSIS; URINARY EXCRETION; VASODILATATION; ALBUMINURIA; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; DIABETIC NEPHROPATHY; FOLLOW UP; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY; VASCULAR ENDOTHELIUM;

ALBUMINURIA; CORONARY ANGIOGRAPHY; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; VASODILATION;

EID: 33644875539     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.29.01.06.dc05-1422     Document Type: Article

References (31)

1. Fuller JH, Stevens LK, Wang SL: Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 44 (Suppl. 2):S54-S64, 2001
2. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106:1777-1782, 2002
3. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo-Perin P: Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetologia 48:427-434, 2005
4. Schachinger V, Britten MB, Zeiher AM: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899-1906, 2000
5. Nitenberg A, Valensi P, Sachs R, Cosson E, Attali JR, Antony I: Prognostic value of epicardial coronary artery constriction to the cold pressor test in type 2 diabetic patients with angiographically normal coronary arteries and no other major coronary risk factors. Diabetes Care 27:208-215, 2004
6. Lerman A, Zeiher AM: Endothelial function: cardiac events. Circulation 111:363-368, 2005
7. Papaioannou GI, Seip RL, Grey NJ, Katten D, Taylor A, Inzucchi SE, Young LH, Chyun DA, Davey JA, Wackers FJ, Iskandrian AE, Ratner RE, Robinson EC, Carolan S, Engel S, Heller GV: Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study). Am J Cardiol 94:294-299, 2004
8. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR: Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42:1017-1025, 1993
9. Nitenberg A, Paycha F, Ledoux S, Sachs R, Attali JR, Valensi P: Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation 97:736-743, 1998
10. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450-458, 1986
11. Enderle MD, Benda N, Schmuelling RM, Haering HU, Pfohl M: Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects. Diabetes Care 21:271-277, 1998
12. Yu Y, Suo L, Yu H, Wang C, Tang H: Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria. Diabetes Res Clin Pract 65:95-104, 2004
13. Henry RM, Ferreira I, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Kamp O, Bouter LM, Stehouwer CD: Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not: the Hoorn Study. Atherosclerosis 174:49-56, 2004
14. Chan JC, Cheung CK, Cheung MY, Swaminathan R, Critchley JA, Cockram CS: Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM. Diabetes Care 18:1013-1016, 1995
15. Fichtlscherer S, Rosenberg G, Walter DH, Breuer S, Dimmeler S, Zeiher AM: Elevated C-reactive protein levels and impaired endothelial vasoreactivity inpatients with coronary artery disease. Circulation 102:1000-1006, 2000
16. Pleiner J, Schaller G, Mittermayer F, Bayerle-Eder M, Roden M, Wolzt M: FFA-induced endothelial dysfunction can be corrected by vitamin C. J Clin Endocrinol Metab 86:2913-2917, 2002
17. Tsioufis C, Dimitriadis K, Antoniadis D, Stefanadis C, Kallikazaros I: Inter-relationships of microalbuminuria with the other surrogates of the atherosclerotic cardiovascular disease in hypertensive subjects. Am J Hypertens 17:470-476, 2004
18. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, et al.: Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26:1235-1241, 1995
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
20. Rosenbaum P, Gimeno SG, Sanudo A, Franco LJ, Ferreira SR: Independent impact of glycemia and blood pressure in albuminuria on high-risk subjects for metabolic syndrome. Clin Nephrol 61:369-376, 2004
21. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE: Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24:471-476, 1994
22. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-1115, 1992
23. Dogra GK, Watts GF, Chan DC, Stanton K: Statin therapy improves brachial artery vasodilator function in patients with type 1 diabetes and microalbuminuria. Diabet Med 22:239 -242, 2005
24. Haines CJ, Yim SF, Sanderson JE: The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris. Atherosclerosis 159:467-470, 2001
25. American Diabetes Association: Dyslipidemia management in adults with diabetes (Position Statement). Diabetes Care 27(Suppl. 1):S68 -S71, 2004
26. Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP: Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 77:43-52, 1988
27. Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S, Matthaei S, Rett K, Haring HU: Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 101:1780-1784, 2000
28. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A: Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101:948-954, 2000
29. Elisaf M, Mikhailidis DP: Statins and renal function. Angiology 53:493-502, 2002
30. Ansquer JC, Foucher C, Rattier S, Taskinen MR, Steiner G, the DAIS Investigators: Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS). Am J Kidney Dis 45:485-493, 2005
31. Nadar S, Blann AD, Lip GY: Antihypertensive therapy and endothelial function. Curr Pharm Des 10:3607-3614, 2004